AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $2.679B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| FLT | Application for quotation of securities - FLT | 04/02/25 | ||
| FLT | FLT Advance Notice Group Half Year Results | 04/02/25 | ||
| FLT | Update on ACCC Test Case | PRICE SENSITIVE | 04/04/18 | |
| FLT | Appendix 3B | 29/03/18 | ||
| FLT | Ceasing to be a substantial holder | 20/03/18 | ||
| FLT | Becoming a substantial holder | 07/03/18 | ||
| FLT | Ceasing to be a substantial holder | 07/03/18 | ||
| FLT | Change of Director's Interest Notice | 07/03/18 | ||
| FLT | Initial Director's Interest Notice | 07/03/18 | ||
| FLT | Appendix 3B | 28/02/18 | ||
| FLT | FLT FY18 Half Year Results Presentation | 22/02/18 | ||
| FLT Application for quotation of securities - FLT | |||
| 04/02/25 | |||
| FLT FLT Advance Notice Group Half Year Results | |||
| 04/02/25 | |||
| FLT Update on ACCC Test Case | |||
| 04/04/18 | PRICE SENSITIVE | ||
| FLT Appendix 3B | |||
| 29/03/18 | |||
| FLT Ceasing to be a substantial holder | |||
| 20/03/18 | |||
| FLT Becoming a substantial holder | |||
| 07/03/18 | |||
| FLT Ceasing to be a substantial holder | |||
| 07/03/18 | |||
| FLT Change of Director's Interest Notice | |||
| 07/03/18 | |||
| FLT Initial Director's Interest Notice | |||
| 07/03/18 | |||
| FLT Appendix 3B | |||
| 28/02/18 | |||
| FLT FLT FY18 Half Year Results Presentation | |||
| 22/02/18 | |||
